Two new analyses link dabigatran to MI risk 

Two new analyses are once again linking the oral direct thrombin inhibitor to an increased risk of MI, especially at the highest dose, but whether this relates to the level of risk in the populations studied or is merely the play of chance is still being debated.

Source: theHeart.org - July 10, 2013 Category: Cardiology Source Type: news